Skip to main content
Pharmaron Beijing Co., Ltd. logo

Pharmaron Beijing Co., Ltd. — Investor Relations & Filings

Ticker · 300759 ISIN · CNE100003JW4 LEI · 300300JYXHGVS5SNGG54 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2025-12-18 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300759

About Pharmaron Beijing Co., Ltd.

https://www.pharmaron.cn

Pharmaron Beijing Co., Ltd. is a premier R&D service provider for the life sciences industry, offering a comprehensive, fully integrated platform for drug discovery, development, and manufacturing. The company supports global pharmaceutical and biotechnology partners through a wide range of services, including laboratory chemistry, biology, DMPK, pharmacology, and safety assessment. Its capabilities extend to clinical development services and commercial-scale manufacturing for small molecules, biologics, and cell and gene therapies. By leveraging advanced technology and a global network of facilities, the company facilitates the transition of drug candidates from initial concept to market approval, optimizing the efficiency and success of the drug development lifecycle.

Recent filings

Filing Released Lang Actions
关于第三届董事会相关董事选举完成的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the completion of the election of directors to the company's third board of directors and the composition of various board committees. It includes names of newly elected independent non-executive directors and committee memberships. There is no financial data, no mention of annual or quarterly reports, no audit results, no voting results from a general meeting, and no other report types. The content clearly relates to changes and composition of the board and its committees, which fits the category of Board/Management Information (MANG). The document length is short and it is a formal announcement of board composition changes, not a report or presentation. Therefore, the correct classification is MANG with high confidence.
2025-12-18 Chinese
北京市中伦律师事务所关于公司2025年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of the 2025 first extraordinary general meeting (临时股东大会) of the company. It details the legality and compliance of the meeting process and voting outcomes but does not contain financial statements or financial performance data. It is not an announcement of voting results per se, but a legal opinion on the meeting's validity and procedures. The document is a standalone legal opinion related to a shareholder meeting, not a full annual report, earnings release, or proxy solicitation. Therefore, it fits best under the category of Regulatory Filings (RNS) as a legal compliance document that does not fit other specific categories.
2025-12-18 Chinese
康龙化成（北京）新药技术股份有限公司章程
Governance Information Classification · 100% confidence The document is titled as the "Articles of Association" (章程) of 康龙化成（北京）新药技术股份有限公司, which is a detailed legal and organizational charter of the company. It includes chapters on company purpose, share capital, shareholders, board of directors, management, financial accounting, profit distribution, audit, notices, mergers, amendments, and other governance matters. It references compliance with Chinese Company Law, Securities Law, and listing rules of Shenzhen and Hong Kong stock exchanges. The document is lengthy (15,000 characters) and contains detailed governance and organizational rules rather than financial statements or earnings data. It is not an announcement or a brief summary but a full governance document. Therefore, it fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-12-18 Chinese
关于选举产生第三届董事会职工代表董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of a new employee representative director to the company's board. It details the election process, the individual's qualifications, and compliance with relevant laws and company bylaws. There is no financial data, no report attached or referenced, and no mention of financial results or regulatory filings. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-12-18 Chinese
关于持股5%以上股东持股变动触及1%整数倍的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding changes in shareholding by shareholders holding more than 5% of the company's shares. It details the reduction in shareholding by specific investors, the percentage changes, and confirms compliance with previously disclosed plans and legal regulations. There is no financial statement or report content, but rather a disclosure of shareholding changes crossing a 1% threshold. This fits the definition of a Major Shareholding Notification (MRQ). The document length and content confirm it is not a brief report publication announcement or a regulatory filing. Therefore, the classification is MRQ with high confidence.
2025-12-11 Chinese
H股公告
Regulatory Filings Classification · 95% confidence The document is a monthly securities movement report for a listed company, detailing changes in registered capital, issued shares, treasury shares, and stock option plans. It references specific stock codes, share classes, and includes detailed tables of share counts and movements for the month ending November 30, 2025. The document is addressed to the Hong Kong Stock Exchange and complies with Chapter 19B of the Listing Rules. It is not an annual or interim financial report, nor an earnings release or management discussion. It is a regulatory filing reporting share capital and shareholding changes, typical of a regulatory compliance report rather than a financial performance report. The document length is 4026 characters, which is relatively short and focused on share capital changes. Therefore, it fits best under Regulatory Filings (RNS), as it is a compliance report on share capital and shareholding changes under listing rules, not a full financial report or announcement of a report.
2025-12-02 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.